Boursorama Sa:企業の戦略・SWOT・財務分析

◆英語タイトル:Boursorama Sa - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3471
◆発行会社(調査会社):MarketLine
◆発行日:2019年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Boursorama Sa – Strategy, SWOT and Corporate Finance Report
Summary

Boursorama Sa – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Boursorama SA (Boursorama), a subsidiary of Societe Generale SA, is a provider of online financial solutions in the areas of banking, financial information, and brokerage. It provides a range of banking solutions such as transactional and investment accounts; debit and credit cards;lending for personal needs, mortgage, property, and other financing requirements; and investment products such as Undertakings for Collective Investment in Transferable Securities (UCITS) and life insurance vehicles, which includes a range of solutions for investing in equities, trackers, warrants, certificates, turbos, deferred settlement service, CFDs, and forex, among others. It provides users access to stock quotes, financial and economic news, and information about companies. Boursorama is headquartered in Cedex, Paris, France.

Scope

- Detailed information on Boursorama Sa required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Boursorama Sa in the form of a SWOT analysis
- An in-depth view of the business model of Boursorama Sa including a breakdown and examination of key business segments
- Intelligence on Boursorama Sa’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Boursorama Sa, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Boursorama Sa and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Boursorama Sa as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Boursorama Sa’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Boursorama SA: Company Overview
Boursorama SA: Overview and Key Facts
Boursorama SA: Overview
Boursorama SA: Key Facts
Boursorama SA: Key Employees
Boursorama SA: Major Products and Services
Boursorama SA: Company History
Boursorama SA: Management Statement
Boursorama SA: Locations and Subsidiaries
Boursorama SA: Key Competitors
Boursorama SA: Company Analysis
Boursorama SA: Business Description
Boursorama SA: SWOT Analysis
Boursorama SA: SWOT Overview
Boursorama SA: Strengths
Boursorama SA: Weaknesses
Boursorama SA: Opportunities
Boursorama SA: Threats
Boursorama SA: Corporate Financial Deals Activity
Boursorama SA: Financial Deals Overview
Boursorama SA: Top Deals 2015 – 2019YTD*
Boursorama SA: Advisors
Boursorama SA: Top Legal Advisors
Boursorama SA: Divestments
Boursorama SA: Recent Developments
Boursorama SA: News and Events Summary
Boursorama SA: Contracts
Boursorama SA: Financial Deals
Boursorama SA: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Boursorama SA: Key Facts
Table 2: Boursorama SA: Key Employees
Table 3: Boursorama SA: Company History
Table 4: Boursorama SA: Locations and Subsidiaries
Table 5: Boursorama SA: Key Competitors
Table 6: Boursorama SA: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Boursorama SA: Top Deals 2015 - 2019YTD*
Table 8: Boursorama SA: Legal Advisor Ranking by Value (US$m)
Table 9: Boursorama SA: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 10: Boursorama SA: Divestments by Geography (2015 - YTD*2019)
Table 11: Boursorama SA: News and Events Summary
Table 12: Boursorama SA: Contracts
Table 13: Boursorama SA: Financial Deals
Table 14: Boursorama SA: Strategy and Operations

★海外企業調査レポート[Boursorama Sa:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BioDiem Ltd-製薬・医療分野:企業M&A・提携分析
    Summary BioDiem Ltd (BioDiem) is a biotechnology company that focuses on developing and commercializing vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal dis …
  • BioClinica Inc:企業の戦略的SWOT分析
    BioClinica Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Pacific Mutual Holding Company:企業の戦略的SWOT分析
    Pacific Mutual Holding Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Metabolomic Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary Metabolomic Technologies Inc (MTI) is a biotechnology company that develops metabolomic-based diagnostic systems. The company's products comprise ColoDx, PolypDx, BreastDx, ProstateDx, CeliacDx, ColitisDx, CrohnsDx and other products. Its products develop advanced diagnostic tests for gastro …
  • Tecumseh Products Company:企業の戦略的SWOT分析
    Tecumseh Products Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Genel Energy Plc (GENL):企業の財務・戦略的SWOT分析
    Genel Energy Plc (GENL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Sol-Gel Technologies Ltd (SLGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Sol-Gel Technologies Ltd (Sol-Gel) is a clinical-stage dermatology company that identifies, develops and commercializes branded and generic topical dermatological drug products for the treatment of skin diseases. The company’s pipeline products include vered, twin and sirs-t drug candidates. …
  • Sembcorp Industries Ltd (U96)-エネルギー分野:企業M&A・提携分析
    Summary Sembcorp Industries Limited (Sembcorp) is a diversified energy, water and marine company. The company’s utilities division provides energy and water to industrial and municipal customers. Its energy operations include power generation, steam production and supply and natural gas import suppl …
  • Ambu AS (AMBU B):企業の財務・戦略的SWOT分析
    Ambu AS (AMBU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Union Bank of India:企業のM&A・事業提携・投資動向
    Union Bank of India - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Union Bank of India Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Ocean Rig UDW Inc (ORIG):石油・ガス:M&Aディール及び事業提携情報
    Summary Ocean Rig UDW Inc (Ocean Rig), formerly Primelead Shareholders Inc is an offshore drilling contractor that offers oilfield services. The company owns and operates 13 offshore ultra deepwater drilling units including ultra deepwater semi submersible drilling rigs, and ultra deepwater drillshi …
  • Pinnacle Biologics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Pinnacle Biologics Inc (Pinnacle Biologics), a subsidiary of Concordia Healthcare Corp. is a drug company that develops and markets photodynamic therapy products. The company offers products such as PHOTOFRIN PI, OPTIGUIDE PI, ETHYOL PI and DIOMED products. Its OPTIGUIDE PI products comprise …
  • Cara Therapeutics Inc (CARA):製薬・医療:M&Aディール及び事業提携情報
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruri …
  • The Ensign Group Inc (ENSG):企業の財務・戦略的SWOT分析
    The Ensign Group Inc (ENSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • PEP-Therapy SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary PEP-Therapy SAS (PEP-Therapy) is a medical biotechnology company that develops targeted therapies for the treatment of cancer. The company develops cell penetrating and interfering peptides for the intracellular delivery of targeted therapies. Its pipeline products include PEP-010. PEP-Thera …
  • Medifast Inc (MED):企業の財務・戦略的SWOT分析
    Medifast Inc (MED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Mobidiag Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Mobidiag Ltd (Mobidiag) is a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products include Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screening of gastrointestin …
  • AirStrip Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary AirStrip Technologies Inc (AirStrip) is a healthcare solution provider that offers medical software solutions and services. The company offers mobile interoperability platform interoperability platform that offers access to critical patient data and intelligent insights across the care conti …
  • COWI AS:企業の戦略的SWOT分析
    COWI AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Ahli Bank Qsc:企業の戦略・SWOT・財務分析
    Ahli Bank Qsc - Strategy, SWOT and Corporate Finance Report Summary Ahli Bank Qsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆